A detailed history of Core Cap Advisors, LLC transactions in Mannkind Corp stock. As of the latest transaction made, Core Cap Advisors, LLC holds 63 shares of MNKD stock, worth $442. This represents 0.0% of its overall portfolio holdings.

Number of Shares
63
Previous 5,063 98.76%
Holding current value
$442
Previous $26,000 100.0%
% of portfolio
0.0%
Previous 0.0%

Shares

6 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 08, 2024

SELL
$5.01 - $6.7 $25,050 - $33,500
-5,000 Reduced 98.76%
63 $0
Q2 2024

Aug 08, 2024

BUY
$4.05 - $5.43 $20,505 - $27,492
5,063 New
5,063 $26,000
Q1 2024

Aug 08, 2024

SELL
$3.25 - $5.27 $16,250 - $26,349
-5,000 Reduced 98.76%
63 $0
Q2 2022

Aug 11, 2022

BUY
$2.67 - $4.77 $534 - $953
200 New
200 $1,000
Q1 2022

Apr 29, 2022

SELL
$2.62 - $4.45 $524 - $890
-200 Closed
0 $0
Q4 2021

Feb 10, 2022

BUY
$4.05 - $5.37 $810 - $1,074
200 New
200 $1,000

Others Institutions Holding MNKD

About MANNKIND CORP


  • Ticker MNKD
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 257,338,000
  • Market Cap $1.81B
  • Description
  • MannKind Corporation, a biopharmaceutical company, focuses on the development and commercialization of inhaled therapeutic products for endocrine and orphan lung diseases in the United States. It offers Afrezza, an inhaled insulin used to improve glycemic control in adults with diabetes. It also promotes Thyquidity to adult and pediatric endocri...
More about MNKD
Track This Portfolio

Track Core Cap Advisors, LLC Portfolio

Follow Core Cap Advisors, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Core Cap Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Core Cap Advisors, LLC with notifications on news.